Sarita, Reexhelyn .

HRN: 00-38-42  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2024
CEFUROXIME 1.5GM (VIAL)
07/08/2024
07/14/2024
IV
1.5
On Call OR
For Repeat CS
Waiting Final Action 
07/09/2024
CEFUROXIME 1.5GM (VIAL)
07/09/2024
07/11/2024
IV
1.5g
Q8hrs
UTI
Waiting Final Action 
07/09/2024
CEFUROXIME 500MG (TAB)
07/09/2024
07/15/2024
PO
500mg
BID
D&c
Waiting Final Action 
07/09/2024
MUPIROCIN 2%, 15G (TUBE)
07/09/2024
07/15/2024
TOPICAL
Apply
BID
S/p Repeat CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: